Nuwellis, Inc., a medical device company, develops, manufactures, and commercializes medical devices used in ultrafiltration therapy. The company provides Aquadex FlexFlow and Aquadex SmartFlow systems, which are used to treat patients suffering from fluid overload due to heart failure, as well as Aquadex SmartFlow system for temporary use in adult and pediatric patients. The company was formerly known as CHF Solutions, Inc. and changed its name to Nuwellis, Inc. in April 2021. Nuwellis, Inc. was founded in 1999 and is headquartered in Eden Prairie, Minnesota.

Employees - 38, CEO - Michael McCormick, Sector - Healthcare, Country - US, Market Cap -

Altman ZScore(max is 10): -64.66, Piotroski Score(max is 10): 3, Working Capital: $2097000, Total Assets: $7166000, Retained Earnings: $-320650000, EBIT: -8288000, Total Liabilities: $4292000, Revenue: $8769000

AryaFin Target Price - $1.25 - Current Price $ - Analyst Target Price $